文献速递妇科

p16/Ki-67双染细胞学用于HPV阳性女性分流:ATHENA试验巢式亚研究结果

Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
PubMed 文献 · Gynecol Oncol · 2016-10-27

该研究基于ATHENA试验横断面阶段,对7727例转诊阴道镜的HPV阳性女性回顾性行p16/Ki-67双染细胞学检测。双染细胞学检出CIN3+的敏感性显著高于Pap细胞学(74.9% vs 51.9%,p<0.0001),特异性相当(74.1% vs 75.0%,p=0.3198)。HPV16/18阳性直接转诊联合其他12型HPV阳性者双染分流敏感性最高(86.8%,95%CI 81.9-90.8)。

要点

  • HPV阳性女性分流中,双染细胞学敏感性74.9%显著高于Pap细胞学51.9%,特异性相当。
  • HPV16/18阳性直接转诊联合其他12型阳性者双染分流,CIN3+敏感性86.8%。
  • 同样策略但用Pap分流其他12型阳性者敏感性78.2%,每检出CIN3+所需阴道镜数相似。

核心结论

  • p16/Ki-67双染细胞学单独或联合HPV16/18基因分型,在primary HPV筛查中对HPV阳性女性阴道镜分流是有前景的敏感高效方法。

研究设计与样本

  • ATHENA试验巢式亚研究,纳入横断面阶段≥25岁、有有效宫颈活检和cobas® HPV检测结果且转诊阴道镜的女性7727例。
  • p16/Ki-67双染细胞学回顾性检测于入组访视时采集的第二份液基细胞学保存的残余细胞学材料。
  • 以活检确诊的CIN3+为终点,比较双染细胞学(联合或不联合HPV16/18基因分型)与Pap细胞学的诊断效能及每检出CIN3+所需阴道镜数。

主要发现

  • 双染细胞学分流HPV阳性女性检出CIN3+的敏感性74.9%,显著高于Pap细胞学的51.9%(p<0.0001)。
  • 双染细胞学特异性74.1%,与Pap细胞学的75.0%相当(p=0.3198)。
  • HPV16/18阳性全部转诊联合其他12型HPV阳性者双染分流,CIN3+敏感性86.8%(95%CI 81.9-90.8)。
  • 同样策略但用Pap分流其他12型HPV阳性者敏感性78.2%(95%CI 72.5-83.2;p=0.0003),每检出CIN3+所需阴道镜数相似。

临床怎么用

  • 在primary HPV筛查中,对HPV阳性女性可采用p16/Ki-67双染细胞学进行阴道镜分流,单独或联合HPV16/18基因分型。

局限性

  • p16/Ki-67双染细胞学为回顾性检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In addition to genotyping for HPV16/18, dual-immunostaining for p16/Ki-67 has shown promise as a triage of HPV-positive women. We assessed the performance of p16/Ki-67 dual-stained cytology for triaging HPV-positive women undergoing primary HPV screening. METHODS: All women ≥25years with valid cervical biopsy and cobas® HPV Test results from the cross-sectional phase of ATHENA who were referred to colposcopy (n=7727) were eligible for enrolment. p16/Ki-67 dual-stained cytology was retrospectively performed on residual cytologic material collected into a second liquid-based cytology vial during the ATHENA enrolment visit. The diagnostic performance of dual-stained cytology, with or without HPV16/18 genotyping, for the detection of biopsy-confirmed cervical intraepithelial neoplasia grade 3 or worse (CIN3+) was determined and compared to Pap cytology. Furthermore, the number of colposcopies required per CIN3+ detected was determined. RESULTS: Dual-stained cytology was significantly more sensitive than Pap cytology (74.9% vs. 51.9%; p<0.0001) for triaging HPV-positive women, whereas specificity was comparable (74.1% vs. 75.0%; p=0.3198). Referral of all HPV16/18 positive women combined with dual-stained cytology triage of women positive for 12 "other" HPV genotypes provided the highest sensitivity for CIN3+ (86.8%; 95% CI: 81.9-90.8). A similar strategy but using Pap cytology for the triage of women positive for 12 "other" HPV genotypes was less sensitive (78.2%; 95% CI: 72.5-83.2; p=0.0003), but required a similar number of colposcopies per CIN3+ detected. CONCLUSIONS: p16/Ki-67 dual-stained cytology, either alone or combined with HPV16/18 genotyping, represents a promising approach as a sensitive and efficient triage for colposcopy of HPV-positive women when primary HPV screening is utilized.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wright TC, Behrens CM, Ranger-Moore J, et al. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Gynecol Oncol. 2016. PMID: 28094038. doi:10.1016/j.ygyno.2016.10.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。